https://www.novumpr.nl/2019/12/07/kite-announces-long-term-data-from-zuma-1-showing-approximately-half-of-refractory-large-b-cell-lymphoma-patients-were-alive-three-years-after-yescarta-treatment/?utm_source=rss&utm_medium=rss&utm_campaign=kite-announces-long-term-data-from-zuma-1-showing-approximately-half-of-refractory-large-b-cell-lymphoma-patients-were-alive-three-years-after-yescarta-treatment NovumPR press releases Sat, 07 Dec 2019 19:19:12 +0000 hourly 1 https://wordpress.org/?v=6.8.3